BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11697722)

  • 1. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.
    Lopaciuk S; Bykowska K; Kwiecinski H; Mickielewicz A; Czlonkowska A; Mendel T; Kuczynska-Zardzewialy A; Szelagowska D; Windyga J; Schröder W; Herrmann FH; Jedrzejowska H
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):346-50. PubMed ID: 11697722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.
    Madonna P; de Stefano V; Coppola A; Cirillo F; Cerbone AM; Orefice G; Di Minno G
    Stroke; 2002 Jan; 33(1):51-6. PubMed ID: 11779888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
    Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.
    Foka ZJ; Lambropoulos AF; Saravelos H; Karas GB; Karavida A; Agorastos T; Zournatzi V; Makris PE; Bontis J; Kotsis A
    Hum Reprod; 2000 Feb; 15(2):458-62. PubMed ID: 10655323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
    M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
    Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.
    Pezzini A; Del Zotto E; Magoni M; Costa A; Archetti S; Grassi M; Akkawi NM; Albertini A; Assanelli D; Vignolo LA; Padovani A
    Stroke; 2003 Jan; 34(1):28-33. PubMed ID: 12511746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
    Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
    Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
    Nowak-Göttl U; Sträter R; Heinecke A; Junker R; Koch HG; Schuierer G; von Eckardstein A
    Blood; 1999 Dec; 94(11):3678-82. PubMed ID: 10572079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the interactions of common genetic mutations in stroke subtypes.
    Szolnoki Z; Somogyvári F; Kondacs A; Szabó M; Fodor L
    J Neurol; 2002 Oct; 249(10):1391-7. PubMed ID: 12382154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.
    Lu Y; Zhao Y; Liu G; Wang X; Liu Z; Chen B; Hui R
    Thromb Res; 2002 Apr; 106(1):7-12. PubMed ID: 12165282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
    Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.
    Günther G; Junker R; Sträter R; Schobess R; Kurnik K; Heller C; Kosch A; Nowak-Göttl U;
    Stroke; 2000 Oct; 31(10):2437-41. PubMed ID: 11022077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.